厄洛替尼-d6,盐酸盐可有效抑制培养的人头和颈部肿瘤细胞中的EGFR自磷酸化,该细胞系表现出高水平的EGFR。厄洛替尼-d6 HCl还抑制PC-9细胞系的增殖,其中PC-9细胞系的EGFR基因外显子19含有缺失突变。厄洛替尼-d6 HCl和雷帕霉素的组合对细胞生长产生协同抑制作用。 Erlontinib-d6 hydrochloride potently inhibits EGFR autophosphorylation in cultured human head and neck tumor cells, a cell line which exhibits high levels of EGFR. Erlotinib-d6 HCl also inhibits the proliferation of PC-9 cell lines, which contain a deletion mutation on exon 19 of the EGFR gene. A combination of Erlotinib-d6 HCl and rapamycin produced a synergistic inhibitory effect on cell growth. Erlotinib-d6, Hydrochloride Saltis a labeled form of Erlontinib HCl, a potent EGFR autophosphorylation inhibitior
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Erlotinib-d6 HCl
CAS number:1189953-78-3 molecular formula:C22H18D6ClN3O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | Tarceva-d3 | N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy-d3)-4-quinazolinamine Hydrochloride | ||
| CAS number | 1189953-78-3 | molecular formula | C22H18D6ClN3O4 |
| molecular weight | 399.48 + 36.46 g/mol | Exact mass | ≥98 atom% D |
| PSA | 74.700 Ų | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





